Ishida Kyoko, Mandal Anil K, Netland Peter A
Hamilton Eye Institute, Department of Ophthalmology, University of Tennessee Health Science Center, 903 Madison Avenue, Suite 100, Memphis, TN 38163, USA.
Ophthalmol Clin North Am. 2005 Sep;18(3):431-42, vii. doi: 10.1016/j.ohc.2005.05.009.
Approximately, one fifth of primary congenital glaucoma patients fail primary surgery. Also, some pediatric glaucomas respond poorly to goniotomy or trabeculectomy. In these situations, clinicians often choose trabeculectomy with mitomycin-C or a drainage implant as a surgical treatment. Glaucoma drainage device implantation is a useful option in refractory patients. When other surgical treatments have a poor prognosis for success, prior conventional surgery fails, or significant conjunctival scarring precludes filtration surgery, glaucoma drainage implant may effectively control intraocular pressure. Patients often require adjunctive glaucoma medications after surgery and may develop complications. Most of these complications, however, are reversible or resolve spontaneously, and most are not associated with vision loss.
大约五分之一的原发性先天性青光眼患者初次手术失败。此外，一些儿童青光眼对前房角切开术或小梁切除术反应不佳。在这些情况下，临床医生通常选择丝裂霉素C小梁切除术或引流植入物作为手术治疗方法。青光眼引流装置植入术对于难治性患者是一种有用的选择。当其他手术治疗成功预后不佳、既往常规手术失败或严重的结膜瘢痕排除滤过手术时，青光眼引流植入物可能有效地控制眼压。患者术后通常需要辅助性青光眼药物治疗，且可能会出现并发症。然而，这些并发症大多是可逆的或可自行缓解，且大多数与视力丧失无关。
